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Body mass index and airway hyper-responsiveness
in individuals without respiratory disease
Summary
Background. Overweight and obesity are major health issues in Western societies.
They are related with a higher risk of different co-morbidities but their relationship
with airway hyperresponsiveness (AHR) is still under discussion. Nevertheless, they
are related to higher severity in asthma and other respiratory diseases. The aim of the
study was to analyze the AHR in individuals with normal lung function without res-
piratory disorders, according to body mass index (BMI) calculation. Methods. We
performed clinical observation and basal lung function tests (LFT) in 595 consecutive
individuals in order to exclude respiratory disease. 377 individuals fulfilled the crite-
ria of normal values according international guidelines. They were submitted to stan-
dardized treadmill exercise test followed by bronchodilator test. FVC, FEV1, FEF
25/75, RV and Raw were obtained at different conditions according to BMI groups
(I: lean; II: normal; III: overweight; IV: obese). Results. 55.2% of the sample was
overweight or obese, and a significant relationship was found with female gender and
older ages (p=0.0046 and p<0.0001 respectively). The positive response to exercise test
or bronchodilator β2 agonists was not significantly frequent compared with the other
groups. In obese individuals the exercise markedly reduced basal Raw and increased
FEF 25/75. Lean individuals showed higher basal values of RV that was reduced
upon exercise. Response to β2 agonists showed no differences according to weight bio-
types. Conclusion. BMI hampers lung function in normal individuals, and seems not
to be related to AHR. Regular exercise should be encouraged in overweight and obese
individuals, since it increases their bronchial permeability as shown in lower frequency
of positive exercise tests. The same is advisable for lean individuals for different rea-
sons. Their increased basal RV and Raw improve upon exercise. Despite overweight
and obesity are being related to a low-grade of basal systemic inflammation, there was
no association with a higher basal bronchial hyperresponsiveness in these individuals.
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Introduction
Many studies have shown that there is a connection be-
tween increased BMI and asthma (1,2). With bronchial
asthma being defined by GINA (Global Initiative for
Asthma) as a chronic inflammation of the airways (3) and
obesity as a pre-inflammatory condition (4), there has
been a special interest in examining how the two are relat-
ed. Additionally, reported incidence of asthma and obesity
has increased in several countries (5-12) and the fact is
that adult patients with asthma tend to be more obese
than those without. In the last few years asthma has in-
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creased in both children and adults (11), with incidence
rates growing as societies become more westernized
(11,12).
Obesity is a public health issue, especially associated to
Western countries. In most European countries its rates
have increased around 10 to 40% over the last few decades
(8). In 2004, Lobstein and partners, in a study based on
data from european countries, showed that the highest
percentage of overweight children (aged between 7 and
10) occurred in the Mediterranean (10). According to In-
ternational Obesity Task Force data (2003-2005, related to
people aged between 18 and 64), in Portugal the percent-
age of overweight people was 39.4% (45.2% for men and
34.4% for women) and the percentage of obese people was
14.2% (15% for men and 13.4% for women) (9).
Obesity is generally considered a cardiovascular risk fac-
tor, but obesity also has an adverse impact on the respira-
tory system, namely as a result of changes in lung func-
tion, respiratory mechanisms, muscular strength and resis-
tance, air exchange, and breathing control (6). Various
studies conducted with both children and adults point to
the correlation between asthma and obesity, showing that
obesity precedes asthma, the relative risk of developing
asthma increases with BMI, and obesity makes asthma
difficult to control or increases its seriousness (13,14).
The possible processes that explain the correlation be-
tween asthma and obesity are in summary, the following:
mechanical effects of obesity, systemic and chronic in-
flammation, energy regulating hormones, co-morbidity
and common etiology (13).
In terms of the mechanical effects of obesity, the decrease
in the lung-thorax compliance is one of the primary con-
sequences of obesity (6,14). Associated to the change in
chest wall elasticity, comes the decrease in residual func-
tional capacity, residual exhalation volume and the width
of the airways, the restriction in deep breathing, a marked
contraction of the smooth respiratory muscle and of the
affected physiological bronchodilation mechanism
(13,15,16). These changes lead to a reduction in lung ca-
pacity, an increase in bronchial hyperresponsiveness and
lung blood levels and a ventilation-perfusion mismatch
(13,14).
We know that obesity is a low-level systemic inflamma-
tion condition. Obese people’s adipose tissues include var-
ious pro-inflammatory molecules such as cytokines,
chemokines, complementary proteins and acute phase
proteins (adipokines) (13,17). There appears to be a sig-
nificant correlation between the immune function of the
adipocytes and the T-lymphoctye and macrophage func-
tion, mainly in the creation of inflammatory cytokines
(17). We also highlight the importance of the energy reg-
ulating hormones in relating asthma to obesity, especially
in terms of leptin and adiponectin (13). Leptin is impor-
tant in appetite-regulation, inducing a feeling of satisfac-
tion or fullness and an increase in metabolic rate. This
hormone occurs in markedly higher levels in obese people
(13,16). Recent studies have suggested that leptin increas-
es the hyperresponsiveness of the airways, albeit through a
mechanism that is independent of Th2 inflammation
13,16,18. Adiponectin, an insulin regulating hormone,
occurs at reduced levels in obesity. This hormone has key
anti-inflammatory functions in obesity, as it inhibits the
production of pro-inflammatory cytokines and increases
the production of IL-10 and the IL-1 inhibitor (19). In-
creasingly, there is a suggestion that adiponectin signifi-
cantly reduces bronchial hyperresponsiveness, inflamma-
tion of the airways and the occurrence of Th2 cells in
lungs (20-22).
Most of the works published on the effect of BMI on res-
piratory function has been based on asthmatic patients.
There are very few studies based on people without a res-
piratory disease or severe breathing problems. In fact it is
a point of discussion whether obesity is a risk factor for
AHR.
The aim of the study was to analyse the AHR in individ-
uals with normal breathing function and without respira-
tory disorders or illness, according different phenotypes
obtained from the BMI calculation.
Material and methods
This was a prospective study conducted between January
to December 2006, obtained by the analysis of 595 con-
secutive both sex individuals sent by medical general prac-
titioner (GP) in order to exclude bronchial and respirato-
ry disease. All of them were submitted to a pletismo-
graphic test (MasterLab Jaeger), undertaken by the same
cardio-respiratory technician. The following protocol was
implemented:
1.Baseline measurements of dynamic volumes, static vol-
umes and airways resistance, as the best of two mea-
sures.
2.Treadmill exercise test (Exer), while breathing ambient
air (20ºC) with a nose clip to ensure mouth breathing,
and cardio monitoring. In order to achieve approxi-
mately 80% of the maximum predicted heart rate (220-
age in years) after a 1 minute warm-up at a lower work
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rate, the patients performed a near maximal constant
load exercise for 6 minutes in a treadmill. At least two
acceptable FEV1 values were obtained at 1 and 5 min-
utes after cessation of exercise and the lowest FEV1 val-
ue was selected to calculate the fall from baseline by the
following equation: % fall in FEV1 = (pre-exercise
FEV1 - lowest FEV1 post-exercise) / pre-exercise
FEV1 x 100%. Those with a fall in FEV1 ≥15% were
considered positive for exercise test.
3.Bronchodilator test (BD), administering an inhaled short
acting β2 inhibitor (100 µg of albuterol) through a spac-
er; the lung function was re-assessed 15 minutes later. It
was considered a positive bronchodilator response an in-
crease in FEV1 and/or FVC ≥12% of control.
The procedures and the technique were according to
ATS/ERS Task Force criteria, as well as the interpretation
of the results (23-26). The following lung function para-
meters were analyzed: forced vital capacity (FVC), forced
expiratory volume at 1 second (FEV1), mean forced expi-
ratory flow between 25% and 75% of FVC (FEF 25/75),
residual volume (RV) and airway resistance (Raw).
All the non-smokers individuals with normal basal lung
function tests (FEV1 and FVC ≥80%) and that had no
clinical evidence of respiratory disease or other relevant
illnesses were included on the study.
This sample was divided into 4 groups, according to the
International Classification of adult BMI – WHO (5)
(Tab. 1).
The difference between gender and age groups was
analysed using the χ2 test. Kruskal-Wallis test was used to
establish the statistical significance of each respiratory
factor and Mann-Whitney test was used to assess the sta-
tistical differences within each BMI group. To study the
impact of physical exercise and bronchial dilation on lung
function, the Wilcoxon Signed Ranks test was used. The
statistical assessment was performed using the SPSS
15.0® program (2006 SPSS Inc, Chicago, Ill, USA).
p<0.05 was considered as the statistical relevance stan-
dard.
Results
Of the 595 people who were tested, 377 met the criteria
defined (238 were women and 139 were men), non-smok-
ers, all without illness and with normal respiratory func-
tion base levels. The average age was 41.33±17.92. The
average BMI was 25.94±4.71.
Table 2 shows the demographic data and lung function
test results according to BMI groups. The results of lung
function parameters in the three steps of evaluation are
shown in figure 1.
55.2% of the individuals were overweight or obese (Group
III and IV), and a significant relationship with female gen-
der (p=0.0046) and older ages was found (p<0.0001).
Group II had the highest FVC basal value. This parame-
ter increased with exercise in almost all the sample, albeit
with greater significance in Group I. The bronchodilator
test improved FVC in all groups but mainly in Groups II,
III and IV.
FEV1 deteriorated with exercise in Groups II and III. In
Group I, this parameter improved but not significantly.
The bronchodilator test improved FEV1 in all Groups,
but more noticeable in Groups II, III and IV.
In terms of the distal air flow, FEF 25/75 average basal
values were highest in Group I. Exercise improved FEF
25/75 for individuals in Groups III and IV, mainly in the
latter. Individuals in Groups I and II (underweight or
normal) and who are as previously mentioned younger,
showed marginally worse levels with exercise.
In lean individuals basal RV values were higher compared
to the other groups. They were slightly reduced by exer-
cise in opposite to obese individuals although without sta-
tistical significance.
Basal airway resistance mean values were higher in group
IV, and markedly reduced by exercise.
Positive exercise challenge test was uncommon among the
total sample, with the overweight and obese individuals
showing curiously the lowest frequencies (Fig. 2). Re-
sponsiveness to bronchodilator was presented at higher
rates, but without significant differences between groups.
Discussion
This study differs from the previous ones, given that the
study population included individuals who had normal
respiratory function according to the criteria established
by ATS/ERS Task Force (23,24), and had no respiratory
disease.
Table 1 - BMI groups according to WHO classification 
Group Classification BMI(kg/m2)
I Underweight <18.50
II Normal range 18.50 – 24.99
III Overweight 25.00 – 29,9
IV Obese ≥30.00
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In order to measure airways reactivity, there are several
tests that can be performed; the methacoline and exercise
challenging tests are the most widely used, but the first
one is better established (26). Although challenge tests
with methacholine are more sensitive in the diagnosis of
AHR than tests with exercise, the last ones are more spe-
cific and may reflect more directly the ongoing airway in-
flammation (27). Also, there are patients with mild
bronchial AHR to methacoline who have negative exer-
cise challenges and others who have positive exercise
challenges but negative methacholine challenges; this can
be indicative of different mechanisms involved in AHR
(27). We chose the exercise challenge test because it is the
most physiological and reflect a natural trigger to AHR;
also, to this date there are very few studies that investigat-
ed exercise induced bronchospasm.
Our results suggest that BMI affects lung function in
people without a respiratory disorder. This agrees with the
data of several other studies, in which it was found that
the lung capacity varied inversely with the body weight
(2, 28-31). The changes in resistance, as a function of
BMI, are also in agreement with these studies, suggesting
that obese people have higher airways resistance (32-34).
One curious found in our study is that underweight peo-
ple also showed higher base level resistance. These data
could be explained by the fact that the BMI groups were
defined by different criteria, depending on the study, and
most of the samples had mainly obese people.
In our study the different BMI groups did not appear to
have more frequently AHR despite having normal respi-
ratory function according to the ATS/ERS criteria
(23,24). Obesity was not linked to an increase in AHR.
Therefore, we conclude that although there is no clear rise
in the frequency of hyperresponsiveness, we suspect that
depending on the clinical conditions which led to obese
patients developing asthma, this would be more serious,
as a result of the bronchial inflammation induced by the
increased synthesis of leptin by the adipocytes and the
systemic inflammation caused by obesity, as a result of in-
creased TNF-α, IL-6 and sIL-6R levels (6,13,17), as sug-
gested by a study published by our group (35). This can
also explain the higher base level of airways resistance in
obese and also overweight people. These groups of indi-
viduals showed less bronchial obstruction following exer-
cise and the best response to bronchodilators. Obese and
overweight subjects tend to have decreased pulmonary
Table 2 - Summary table with main lung function test results by BMI grouping. Values are shown as average percentage with stan-
dard deviations
Group I Group II Group III Group IV
N 16 153 128 80
Female 8 87 84 59
Male 8 66 44 21
Average age 10.56±4,89 34.62±16,66 47.84±15,39 49.9±13,66
FVC 86.61±6.03 98.19±11.64 96.77±12.56 96.74±11.92
FVC – exercise 100.36±7.44 98.43±7.18 99.45±6.67 98.75±6.25
FVC – BD 102.80±7.19 102.11±6.91 103.18±7.70 103.23±7.05
FEV1 100.43±8.37 106.56±11.02 104.77±11.98 104.36±13.27
FEV1 – exercise 100.75±6.38 99.95±5.69 101.39±5.28 101.71±6.16
FEV1 – BD 102.34±5.17 103.07±5.59 103.33±6.01 104.61±6.59
FEF 25/75 119.89±23.98 110.42±29.49 103.32±28.00 102.06±24.40
FEF 25/75 – exercise 108.40±12.94 105.77±16.51 107.68±16.08 113.03±20.85
FEF 25/75 – BD 106.29±15.37 107.95±18.03 105.84±21.23 110.88±20.31
RV 116.61±22.26 100.64±29.62 93.68±25.35 90.11±30.53
RV – exercise 98.57±41.43 112.69±44.79 101.17±33.31 111.93±75.59
RV – BD 92.33±21.82 106.32±48.64 98.54±27.48 103.09±43.24
RAW 135.85±51.39 93.51±43.59 125.00±68.35 146.03±84.09
RAW – exercise 125.49±32.89 108.25±39.81 102.22±36.56 96.21±36.98
RAW – BD 103.88±20.41 96.37±30.84 94.37±31.82 89.84±32.29
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Figure 1 - Effects of BMI on FVC, FEV1, FEF25/75, RV and resistance (RAW), according to lung function tests.The horizontal lines are
the between-group comparisons from Wilcoxon Signed Ranks and Mann-Whitney tests.The vertical lines are the error bars (2 SD)
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volumes and less thoracic wall distensibility (36); they
have a more sedentary life and are not used to exercise, so
with physical activity they have to exercise muscles, other-
wise not employed, and better coordinate their respiratory
movements, which can explain a better bronchomotricity.
The role of obesity on AHR is controversial, as arise from
the analysis of several studies. In 2006, a study undertak-
en by Johnston and cols concluded that obese rats showed
increased lung response to ozone, and that the inhalation
of this gas increased resistance, hyperresponsiveness and
inflammation of the airways (37). These results were then
reproduced in human, where some studies showed higher
increase in AHR and a reduction in lung function re-
sponse to ozone in overweight as opposed to underweight
individuals (38,39). Chinn and cols, 2002, showed that
there was a significant correlation between bronchial hy-
perresponsiveness to methacoline and BMI, but only in
men (40). Another study published in 2002, conducted in
men participating in the Normative Aging Study, associ-
ated both a low BMI and a high BMI with the develop-
ment of AHR to methacholine (41). Although our study
did not find a relation between BMI and AHR, under-
weight and obese individuals had the lowest basal FEV1
and FCV levels and the highest basal resistance levels,
and exercise improved the general lung function parame-
ters. The differences between the studies referred before
and our study can be explained by the less sensitivity and
more specificity of exercise challenge tests in the diagno-
sis of AHR (27), as already explained. Also, we have
highlighted before that obese people do not have a regular
physical activity, so exercise can bring a better respiratory
coordination and muscles utilization, facts that can ex-
plain the respiratory improvement with exercise in these
individuals. Other studies showed no correlation between
BMI and AHR. Schachtern and partners in 2001 did not
find any connection between serious obesity and AHR to
histamine challenge, despite obesity being a factor for
asthma and wheezing (42). Weight loss did not lead to a
reduction in bronchial hyperresponsiveness to methacol-
ine in a group of obese women (43).
Various studies have attempted to establish the relation-
ship between obesity and asthma, and have reached di-
verse conclusions. In 2005 a review of several studies con-
cluded that adult asthma patients are more obese than
those without asthma, but in children and adolescents this
correlation is less marked (1). The prevalence of asthma
is higher in obese individuals, as obesity underlines a
worse clinical history (16). Longitudinal studies show that
obesity precedes asthma and that the risk of asthma am-
plifies with increasing BMI (44,45). Obesity is related to
Figure 2 - Exercise challenge and positive bronchodilator tests (as a %), distributed by BMI Groups
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a worse clinical history and makes the asthma more diffi-
cult to control (13,43). One interesting study was con-
ducted with perimenopausal women, which established
that underweight and obese women showed the highest
risk of having impaired lung function and of developing
asthma. In underweight women the explanation was that
the fatty tissue produces less oestrogen, while in obese
women the explanation arises from insulin-resistance, as
this is a pro-inflammatory factor (46).
Our results stress that BMI seems not be related to higher
risk of AHR, namely in overweight and obese individuals.
They must be asked for regular exercise, because they in-
crease their bronchial permeability besides the lower posi-
tivity to exercise test. Lean individuals should also be
asked for regular exercise, because they decrease the values
of basal RV and Raw. Despite the lower frequency of pos-
itive broncoresponsiveness tests in our study among over-
weight and obese individuals we strong believe that if
asthma occurs in those, it definitely contributes to a se-
vere clinical phenotype, developed on a previous low-
grade inflammatory state already described.
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